Home » Topics » Regulatory » Patents

Patents
RSS

Sumitomo Dainippon Pharma develops PDE1 inhibitors

Oct. 6, 2016

The Vanderbilt University reports mGlu2 receptor negative allosteric modulators

Oct. 5, 2016

GlaxoSmithKline presents bromodomain inhibitors

Oct. 5, 2016

Bristol-Myers Squibb describes TNF-alpha antagonists

Oct. 5, 2016

Heptares Therapeutics discloses muscarinic M1 and M4 receptor agonists

Oct. 5, 2016

Merck & Co. patents PDE2A inhibitors

Oct. 5, 2016

Calitor Sciences and Sunshine Lake Pharma present PI3K inhibitors

Oct. 4, 2016

Korea University Research and Business Foundation develops TSLP ligands

Oct. 4, 2016

Eli Lilly describes BACE1 inhibitors

Oct. 4, 2016

Oncodesign discloses ALK-1 and/or ALK-2 inhibitors

Oct. 4, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...